BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38307213)

  • 1. Incidence of Strabismus Post-Plaque Brachytherapy in Patients With Uveal Melanoma.
    Huang JJ; Saleem A; Liao EX; Larocque M; Menon G; Murtha A; Solarte C; Weis E
    Am J Ophthalmol; 2024 Jun; 262():161-169. PubMed ID: 38307213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma.
    Sener EC; Kiratli H; Gedik S; Sanac AS
    J AAPOS; 2004 Feb; 8(1):38-45. PubMed ID: 14970798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy.
    Dawson E; Sagoo MS; Mehta JS; Comer R; Hungerford J; Lee J
    J AAPOS; 2007 Dec; 11(6):584-8. PubMed ID: 17588793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural alterations in extraocular muscles following iodine-125 brachytherapy for uveal melanoma.
    Kïratlï H; Yïlmaz PT; Sargon M
    Strabismus; 2007; 15(2):103-9. PubMed ID: 17564940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of strabismus following choroidal melanoma plaque brachytherapy.
    Alfreihi SH; Pineles SL; McCannel TA; Prada AM; Velez FG
    J AAPOS; 2017 Aug; 21(4):286-290.e2. PubMed ID: 28728906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
    Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
    J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
    Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
    Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma.
    Nagendran ST; Finger PT; Campolattaro BN
    Ophthalmology; 2014 Nov; 121(11):2268-74. PubMed ID: 25062940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
    Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
    Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
    Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
    Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
    McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
    Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
    Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
    Retina; 2008; 28(7):987-95. PubMed ID: 18698302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression patterns of choroidal melanoma: After palladium-103 (
    Maheshwari A; Finger PT
    Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.